0 Comentários
0 Compartilhamentos
607 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça Login para curtir, compartilhar e comentar!
-
Alzheimer's Disease and Dementia Diagnostics & Treatment Market: Global Industry Trends, Regional Revenue Share, and Growth Forecast, 2026–2033According to the latest report published by Data Bridge Market Research, the Dementia - Alzheimer Disease Market Data Bridge Market Research analyses that the market, which was USD 13,000.00 million in 2022, would rocket up to USD 25,000.00 million by 2030 and is expected to undergo a CAGR of 8.5% during the forecast period. A large scale Dementia - Alzheimer Disease...0 Comentários 0 Compartilhamentos 115 Visualizações 0 Anterior
-
Alzheimer's Disease and Dementia Diagnostics & Treatment Market: Global Industry Trends, Regional Revenue Share, and Growth Forecast, 2026–2033According to the latest report published by Data Bridge Market Research, the Dementia - Alzheimer Disease Market Data Bridge Market Research analyses that the market, which was USD 13,000.00 million in 2022, would rocket up to USD 25,000.00 million by 2030 and is expected to undergo a CAGR of 8.5% during the forecast period. A large scale Dementia - Alzheimer Disease...0 Comentários 0 Compartilhamentos 135 Visualizações 0 Anterior
-
Alzheimer's Disease Diagnostic Market Size, Share, Industry Analysis and Forecast 2026-2033"According to the latest report published by Data Bridge Market Research, the Alzheimer's Disease Diagnostic Market Data Bridge Market Research analyses that the alzheimer's disease diagnostic market was valued at USD 10,376.30 million in 2022 and is expected to reach the value of USD 22,454.74 million by the year 2030, at a CAGR of 9.40% during the forecast period. An...0 Comentários 0 Compartilhamentos 314 Visualizações 0 Anterior
-
Alzheimer's Disease Diagnostic Market: How Is the Alzheimer's Diagnostic Market Being Transformed by New Treatments?FDA-approved amyloid-targeting therapies — lecanemab (Leqembi) and donanemab (Kisunla) receiving FDA approval for early AD treatment — have fundamentally transformed Alzheimer's diagnostics from a primarily academic exercise toward a clinically necessary component of treatment pathway qualification, with the Alzheimer's Disease Diagnostic Market reflecting the treatment-driven...0 Comentários 0 Compartilhamentos 524 Visualizações 0 Anterior
-
Alzheimer's Disease Therapeutics Market: Pipeline Drugs, Biomarker Innovation, and Market Size Forecast"Competitive Analysis of Executive Summary Alzheimer’s Disease Market Size and Share Data Bridge Market Research analyzes that the Alzheimer’s disease market which was USD 5.10 billion in 2022, is likely to reach USD 9.73 billion by 2030, and is expected to undergo a CAGR of 8.40% during the forecast period. To stand apart from the competition, a careful idea about the...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
Alzheimer's therapeutics market analysis of early-stage cognitive impairment and dementia treatment up to 2032Alzheimer’s Therapeutics Market Overview The Alzheimer’s Therapeutics Market report provides an in-depth analysis that is required to make informed industry decisions and develop strategic growth plans. Regardless of the production method or cost structures, the Alzheimer’s Therapeutics market report provides a full understanding of advanced...0 Comentários 0 Compartilhamentos 8 Visualizações 0 Anterior
-
Alzheimer’s Disease Biomarkers Market to Surpass US$ 1.7 Bn by 2031, Driven by Rising Dementia Prevalence and Advances in Early DiagnosisThe global Alzheimer’s disease biomarkers market is witnessing steady expansion as the prevalence of Alzheimer’s disease and other forms of dementia continues to rise worldwide. Alzheimer’s disease is a progressive and irreversible neurodegenerative disorder that affects memory, cognition, behavior, and functional independence. Biomarkers provide measurable indicators of...0 Comentários 0 Compartilhamentos 67 Visualizações 0 Anterior
-
Alzheimer’s Disease Diagnostic Market Key Manufacturers: Leading Players and StrategiesThe Alzheimer’s Disease Diagnostic Market Key Manufacturers include Roche, GE Healthcare, Siemens Healthineers, Eli Lilly, and Biogen. These companies dominate due to strong R&D capabilities, broad distribution networks, and robust product portfolios. Imaging solutions, biomarker assays, and AI-assisted diagnostics remain core revenue drivers. Key manufacturers are focusing on...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
Alzheimer’s Disease Diagnostic Market: How Is the Brazil Public‑Health System Catching Up in the Alzheimer’s Disease Diagnostic Market?Brazil’s aging population is reshaping the Alzheimer’s Disease Diagnostic Market, as rising dementia prevalence drives demand for earlier, more accurate diagnostic tools. Alzheimer’s Disease Diagnostic Market Growing dementia burden and late‑diagnosis gap Millions of Brazilians live with Alzheimer’s or related dementias, yet many cases are diagnosed only at...0 Comentários 0 Compartilhamentos 392 Visualizações 0 Anterior
-
Alzheimer’s Disease Market Size & Future Forecast"Executive Summary Alzheimer’s Disease Market Trends: Share, Size, and Future Forecast Data Bridge Market Research analyzes that the Alzheimer’s disease market which was USD 5.10 billion in 2022, is likely to reach USD 9.73 billion by 2030, and is expected to undergo a CAGR of 8.40% during the forecast period. The Alzheimer’s Disease Market report...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
Alzheimer’s Disease Treatment Market Analysis and Growth Outlook"What’s Fueling Executive Summary Alzheimer’s Disease Treatment Market Market Size and Share Growth Data Bridge Market Research analyses that the Alzheimer’s disease treatment will exhibit a CAGR of around 8.79% for the forecast period of 2022-2029. To stand apart from the competition, a careful idea about the competitive landscape, their product range, their...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
Global Neuroprotective Agents Market Growing at 7.1% CAGR Through 2034According to a new report from Intel Market Research, the global Neuroprotective Agents Market was valued at USD 5.8 billion in 2025 and is projected to grow from USD 6.3 billion in 2026 to USD 10.9 billion by 2034, exhibiting a robust CAGR of 7.1% during the forecast period (2026–2034). This growth is propelled by the escalating burden of neurodegenerative diseases, a rapidly aging...0 Comentários 0 Compartilhamentos 420 Visualizações 0 Anterior
Páginas Impulsionadas
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek